Comparing the effects of adding Vagifem and vaginal Premarin in increasing endometrial thickness and pregnancy rate in IVF patients whose endometrial thickness was not responsive to conventional regimens, in Shiraz.

Trial Profile

Comparing the effects of adding Vagifem and vaginal Premarin in increasing endometrial thickness and pregnancy rate in IVF patients whose endometrial thickness was not responsive to conventional regimens, in Shiraz.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Conjugated estrogens (Primary) ; Estradiol (Primary) ; Estrogen
  • Indications Female infertility
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Jan 2014 According to Iranian Registry of Clinical Trials record, status changed from recruiting to active, no longer recruiting.
    • 29 Nov 2013 Recruitment complete.
    • 31 May 2013 Status changed from not yet recruiting to recruiting as reported by Iranian Registry of Clinical Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top